logo-loader
AIM:PYC

Physiomics PLC

Receive alerts
Market:
AIM
Price
1.23 GBX
Day Change
-5.38%
Market Cap:
£1.67 m
52 weeks high
4.26
52 weeks low
0.90

In brief

Physiomics is a solutions provider to the R&D-based pharmaceutical and biotechnology industry with a focus on oncology. The company uses a combination of industry standard and its own proprietary Virtual Tumour modelling technologies to predict the effects of cancer drugs and treatments to improve the success rate of drug discovery and development projects while reducing time and cost. The predictive capability of Virtual Tumour has been confirmed by over 60 projects, involving over 25 targets and 60 drugs.